Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Viola mandshurica** is a perennial herb in the Violaceae family, native to East Asia (Korea, Japan, China, Russia, and Siberia), used historically in traditional medicine. It has been studied for various biological activities, particularly as an **anti-inflammatory**, expectorant, and diuretic. Extracts (notably fermented and chloroform extracts) demonstrate suppression of pro-inflammatory mediators by inhibiting inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), as well as the NF-κB, ERK, and JNK pathways. Identified constituents include tectoridin, luteolin, resveratrol, and hesperetin. It has been investigated for uses in bronchitis, rheumatism, skin eruptions, eczema, asthma, obesity, hyperlipidemia, and possibly viral infections. Usage is primarily as a **dietary supplement/herbal extract** in traditional practices, not a regulated pharmaceutical drug[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on viola mandshurica.